...
首页> 外文期刊>Gene therapy >Current application of CRISPR/Cas9 gene-editing technique to eradication of HIV/AIDS
【24h】

Current application of CRISPR/Cas9 gene-editing technique to eradication of HIV/AIDS

机译:CRISPR / CAS9基因编辑技术在消除艾滋病毒/艾滋病的应用

获取原文
获取原文并翻译 | 示例
           

摘要

Human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS) remains a major health hazard despite significant advances in prevention and treatment of HIV infection. The major reason for the persistence of HIV/AIDS is the inability of existing treatments to clear or eradicate the multiple HIV reservoirs that exist in the human body. To suppress the virus replication and rebound, HIV/AIDS patients must take life-long antiviral medications. The clustered regularly interspaced palindromic repeats (CRISPR)/CRISPR-associated nuclease 9 (Cas9) system is an emerging gene-editing technique with the potential to eliminate or disrupt HIV-integrated genomes or HIV-infected cells from multiple HIV reservoirs, which could result in the complete cure of HIV/AIDS. Encouraging progress has already been reported for the application of the CRISPR/Cas9 technique to HIV/AIDS treatment and prevention, both in vitro in human patient cells and in vivo in animal model experiments. In this review, we will summarize the most recent progress in the application of the CRISPR/Cas9 gene-editing technique to HIV/AIDS therapy and elimination. Future directions and trends of such applications are also discussed.
机译:尽管预防和治疗HIV感染的显着进展,人类免疫缺陷病毒(HIV)/获得的免疫缺陷综合症(AIDS)仍然是一个重大的健康危害。艾滋病毒/艾滋病持续存在的主要原因是现有的治疗方法清除或消除存在于人体中存在的多个艾滋病病毒储层。为了抑制病毒复制和反弹,艾滋病毒/艾滋病患者必须服用终身抗病毒药物。聚类定期间隙的回文重复(CRISPR)/ CRISPR相关的核酸酶9(CAS9)系统是一种新兴基因编辑技术,具有消除或破坏来自多个HIV储层的HIV综合基因组或HIV感染细胞的潜力,这可能会导致在完全治愈艾滋病毒/艾滋病。令人鼓舞的进展已经据报道,在人类患者细胞和动物模型实验中的体外,在体外申请CRAPR / CAS9技术对艾滋病毒/艾滋病治疗和预防。在本综述中,我们将总结CRISPR / CAS9基因编辑技术在艾滋病毒/艾滋病治疗和消除中施加最新进展。还讨论了此类应​​用的未来方向和趋势。

著录项

  • 来源
    《Gene therapy》 |2017年第7期|共8页
  • 作者单位

    Florida Int Univ Dept Immunol Inst NeuroImmune Pharmacol Ctr Personalized Nanomed Herbert;

    Florida Int Univ Dept Immunol Inst NeuroImmune Pharmacol Ctr Personalized Nanomed Herbert;

    Florida Int Univ Dept Immunol Inst NeuroImmune Pharmacol Ctr Personalized Nanomed Herbert;

    Florida Int Univ Dept Immunol Inst NeuroImmune Pharmacol Ctr Personalized Nanomed Herbert;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 治疗学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号